Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
pembrolizumab programmed cell death protein 1 biotech Successful target TTD , drugbank , DGIDB Triple Negative Breast Neoplasms[MeSHID:D064726]
Malignant Neoplasms[MeSHID:D009369]
melanoma[MeSHID:D008545]
Carcinoma[MeSHID:D002277]
Squamous Epithelial Cells[MeSHID:D004847]
Urinary Bladder[MeSHID:D001743]
Renal Cell Carcinoma[MeSHID:D002292]
Malignant neoplasm of urinary bladder[MeSHID:D001749]
Operative Surgical Procedures[MeSHID:D013514]
Muscle[MeSHID:D009132]
Disease Progression[MeSHID:D018450]
Recurrence (disease attribute)[MeSHID:D012008]
Merkel cell carcinoma[MeSHID:D015266]
Malignant neoplasm of muscle[MeSHID:D019042]
Stomach[MeSHID:D013270]
Microsatellite Instability[MeSHID:D053842]
Neoplasm Metastasis[MeSHID:D009362]
Mismatch Repair[MeSHID:D053843]
cervical cancer[MeSHID:D002583]
Mutation[MeSHID:D009154]
Carcinoma in Situ[MeSHID:D002278]
B-Cell Lymphomas[MeSHID:D016393]
Squamous cell carcinoma[MeSHID:D002294]
Endometrial Carcinoma[MeSHID:D016889]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Carcinoma
Transitional Cell[MeSHID:D002295]
Liver carcinoma[MeSHID:D006528]
Disease[MeSHID:D004194]
Adenocarcinoma[MeSHID:D000230]
Cancer of Head and Neck[MeSHID:D006258]
Colorectal Cancer[MeSHID:D015179]
Malignant neoplasm of stomach[MeSHID:D013274]
Unmarried[MeSHID:D012847]
Esophageal Neoplasms[MeSHID:D004938]
Hodgkin Disease[MeSHID:D006689]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant neoplasm of prostate[MeSHID:D011471]
Small cell carcinoma of lung[MeSHID:D055752]
Malignant neoplasm of ovary[MeSHID:D010051]
Malignant neoplasm of breast[MeSHID:D001943]		 1.03 approved inhibitor,antibody
click here to return to the previous page